Free CNOR Exam Flashcards

To match the intended patient to the planned care, medications, specimens, and documentation. Use two approved person-specific identifiers; a room or bed number is not a patient identifier.

Stop progression toward the procedure and resolve the discrepancy through the appropriate team and chain of command. Do not infer which source is correct.

Prescribed and over-the-counter drugs, supplements and herbals, recent perioperative medications, allergies or reactions, and relevant substance use. The goal is to identify omissions, duplication, interactions, and bleeding or anesthesia risks.

The reaction helps distinguish intolerance from hypersensitivity and guides risk controls, substitutions, and emergency preparation. Clarify the exposure and the patient's observed response whenever possible.

It connects baseline findings to the planned procedure and anesthesia: airway and cardiopulmonary status, skin and mobility, pain, relevant labs, fasting status, devices, and procedure-specific preparation.

Confirm its current status, ensure the perioperative plan reflects the required discussion and orders, and escalate any ambiguity before proceeding. Do not silently assume that an existing directive is suspended or unchanged.

Readiness, developmental level, preferred language, health literacy, culture, cognition, sensory needs, anxiety, support system, and the patient's stated goals. Confirm understanding with an appropriate feedback method.

Assessment evidence about the patient's actual or potential response to surgery, anesthesia, and the environment. The diagnosis should not be selected merely because a particular procedure is scheduled.

It identifies the patient response to be observed and a clear criterion or condition for judging whether the outcome was achieved across the care continuum.

Each intervention should address an identified diagnosis and make the expected outcome more likely. It should be individualized for the patient's risks, values, age, devices, and procedure.

Whenever new assessment data, the patient's response, or a change in the procedure makes the existing diagnoses, interventions, or outcomes inaccurate or unsafe.

Compare the patient's observed response with the measurable expected outcome, determine whether interventions worked, and continue, modify, or escalate the plan based on that comparison.

Immediately before the procedure or incision, with active participation by the immediate procedure team. The team confirms the correct patient, procedure, and site and resolves any disagreement before starting.

Treat it as contaminated, announce the concern, isolate or replace the affected item, and restore the field before continuing. Uncertainty is not evidence of sterility.

Notify the surgeon and team, repeat and reconcile the count, search the field and room, and follow the facility's retained-item protocol, including imaging when indicated. Document the actions and outcome.

Immediately when it is prepared or transferred, unless it is administered at once by the same person without interruption. The label must support unambiguous identification under facility policy.

Correctly identify the patient and specimen, verify the source or site, use the required container and preservative, label accurately, communicate special handling, document it, and maintain traceable transport.

Maintain alignment and physiologic function, protect nerves and pressure points, and secure the patient without impairing circulation or ventilation. Reassess after positioning and whenever the table or procedure changes.

They define compatible accessories, setup, operation, processing, inspection, and limitations for that device. Habit or a similar device's instructions cannot substitute for the applicable IFU.

An ignition source, a fuel, and an oxidizer. Prevention works by controlling all three, especially where supplemental oxygen can accumulate near an ignition source.

Capture it close to the source with an effective local smoke-evacuation system. Room ventilation and personal protective equipment do not replace source capture.

The correct implant and required components are available for the correct patient and procedure, package integrity and expiration are acceptable, processing requirements are met, and traceability information can be recorded.

Anticipate equipment and positioning needs, monitor the patient's response and environment, communicate changes promptly, and perform only actions within role, competence, orders, and facility policy.

Limit exposure to what the procedure requires, protect privacy during positioning and transport, communicate respectfully, and advocate for the patient while the patient cannot self-advocate.

Correct item, expiration or use-by status, package integrity, dryness, indicator results when applicable, and evidence that storage conditions were maintained.

Law and regulation, facility policy, the task's predictability and risk, and the delegatee's role and verified competence. The RN remains responsible for appropriate delegation and follow-up.

Provide product-specific technical information within facility policy and under supervision. The representative does not replace licensed clinical judgment, perform unauthorized patient care, or independently direct the procedure.

Patient and staff safety, clinical effectiveness, compatibility, processing and training needs, reliability, waste, supply continuity, and total cost of use.

Waste reduction and resource conservation must remain consistent with infection prevention, patient safety, regulatory requirements, and manufacturer instructions.

Patient identity, procedure and course, current physiologic status, allergies, medications, pain, wounds and drains, implants, specimens, blood loss or fluids, safety concerns, and pending actions.

The receiver repeats the information so the sender can confirm or correct it, closing the communication loop before the order or result is acted upon.

It is timely, accurate, objective, complete, attributable, and consistent with the care delivered. It records assessments, interventions, patient responses, communications, and required traceability without speculation.

Identify the barrier early and use qualified interpretation or appropriate assistive resources. Confirm understanding directly with the patient rather than relying on assumptions or unqualified intermediaries.

The patient meets the applicable transfer criteria, the receiving team accepts a complete handoff, required records and belongings accompany the patient, and unresolved risks or pending actions are explicit.

Its intended contact during use: critical items enter sterile tissue or the vascular system, semicritical items contact mucous membranes or nonintact skin, and noncritical items contact intact skin.

Sterilization before use, because the device enters sterile tissue or the vascular system. The chosen validated method must be compatible with the device's instructions for use.

Semicritical devices require at least high-level disinfection; noncritical devices generally require low-level disinfection. The device IFU and applicable policy may require a higher level.

Organic and inorganic soil can shield microorganisms and interfere with the process. Cleaning reduces soil and bioburden so the validated disinfectant or sterilant can contact device surfaces.

Use the device-specific point-of-use treatment, contain sharps safely, and transport items promptly in a closed, secure, leak-resistant, labeled container that protects staff and prevents drying or loss.

Physical monitors show cycle parameters, chemical indicators show exposure to selected conditions, and biological indicators directly challenge the process with resistant spores. No single monitor replaces the others.

Do not use it as sterile. Remove it from use and follow the applicable reprocessing or disposal process; an intact-looking item inside does not restore package sterility.

No. Perform hand hygiene at the indicated times before donning and after removing gloves, and change gloves when contamination or task transitions require it. Select additional PPE from the anticipated exposure.

Recognize and announce the emergency, stop or remove the suspected trigger when feasible, call for help and activate the applicable protocol, support airway-breathing-circulation, assign roles, and document events and responses.

A rapidly rising end-tidal CO2 with tachycardia or rigidity is an early warning; temperature rise may be late. Stop triggering agents, call for help and the MH cart, hyperventilate with 100% oxygen, and give IV dantrolene per the MH protocol.

Neurologic symptoms such as tinnitus, metallic taste, agitation, or seizure may progress to dysrhythmia and cardiovascular collapse. Stop local anesthetic delivery, support the airway and circulation, summon help, and activate the facility's LAST checklist with early lipid-emulsion therapy.

Anaphylaxis requires prompt epinephrine while the trigger is stopped and airway, oxygenation, circulation, and additional resuscitation are supported. Antihistamines are adjuncts, not substitutes for epinephrine.

Call for help and activate the hemorrhage or transfusion protocol, support circulation and oxygenation, identify and control the source, obtain rapid access and testing, warm the patient and products as indicated, and maintain closed-loop communication.

Do not perform it independently. State the limitation, seek qualified assistance, use the chain of command, and continue protecting the patient within the nurse's authorized role.

Intervene to protect the patient, communicate the safety concern, and report or escalate through the facility's established process. Hierarchy does not cancel the duty to advocate.

Evidence-based practice integrates best evidence, clinical expertise, and patient preferences to guide care. Quality improvement uses local process and outcome data to test and sustain better performance in a specific system.